Skip to content

strategy for adequate blood pressure lowering in the patients with intracranial atherosclerosis

strategy for adequate blood pressure lowering in the patients with intracranial atherosclerosis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0000351
Enrollment
140
Registered
2012-02-09
Start date
2009-11-02
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : maintain systolic BP (1) below 120mmHg or (2) 140-150mmHg by using 5mg to 10mg Amodipine

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with hypertension and intracranial atherosclerosis among acute stroke patients who were admitted in Neurology department of 4 hospitals in Korea

Exclusion criteria

Exclusion criteria: patients with cardioembolic stroke

Design outcomes

Secondary

MeasureTime frame
occurrence of complicated cardiovascular events

Primary

MeasureTime frame
any new lesion on FLAIR MRI

Countries

Korea, Republic of

Contacts

Public ContactYoungshin Yoon

Asan Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026